Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?

Podobne zapisy

• Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment
  od: Cogen, Jonathan D., i wsp.
  Wydane: (2021)
• Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis
  od: Somayaji, Ranjani, i wsp.
  Wydane: (2019)
• Azithromycin and the microbiota of cystic fibrosis sputum
  od: Acosta, Nicole, i wsp.
  Wydane: (2021)
• Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
  od: Nichols, Dave P., i wsp.
  Wydane: (2020)
• Pulmonary exacerbations in cystic fibrosis and bronchiectasis
  od: Elborn, J S, i wsp.
  Wydane: (2007)